Alphabet’s Isomorphic Labs raised $600 million in its first funding round, led by Thrive Capital and Google Ventures, to advance its AI-driven drug discovery mission: “solving all disease.” Founded by Demis Hassabis, the London-based lab behind the Nobel-winning AlphaFold plans to boost research and expand its team with this investment.
Read more on nypost
